[1] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组.  新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志, 2020, 41(2): 145-151.   doi: 10.3760/cma.j.issn.0254-6450.2020.02.003
Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention.  The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China[J]. Chin J Epidemiol, 2020, 41(2): 145-151.   doi: 10.3760/cma.j.issn.0254-6450.2020.02.003
[2] 肖玉玲, 陆小军, 康梅, 等.  2019新型冠状病毒疫情下医院检验科的生物安全实施方案探讨[J]. 中华检验医学杂志, 2020, 43(5): 511-514.   doi: 10.3760/cma.j.cn114452-20200214-00070
Xiao YL, Lu XJ, Kang M, et al.  The management of biosafety risk in clinical laboratory of hospital during the outbreak of COVID-19[J]. Chin J Lab Med, 2020, 43(5): 511-514.   doi: 10.3760/cma.j.cn114452-20200214-00070
[3]

中华人民共和国国家卫生健康委员会办公厅. 国家卫生健康委办公厅关于印发新型冠状病毒感染的肺炎防控中常见医用防护用品使用范围指引(试行)的通知[EB/OL]. (2020-01-27)[2021-02-03]. http://www.nhc.gov.cn/xcs/zhengcwj/202001/e71c5de925a64eafbe1ce790debab5c6.shtml.

General Office of National Health Commission of the People's Republic of China. Notice of the General Office of the National Health Commission on the issuance of guidelines on the scope of use of common medical protective articles in the prevention and control of pneumonia infected by 2019 novel coronavirus (trial)[EB/OL]. (2020-01-27)[2021-02-03]. http://www.nhc.gov.cn/xcs/zhengcwj/202001/e71c5de925a64eafbe1ce790debab5c6.shtml.
[4] 张敬勉, 王建方, 赵新明.  新型冠状病毒肺炎疫情防控期核医学诊疗工作的防护建议[J]. 国际放射医学核医学杂志, 2020, 44(10): 622-626.   doi: 10.3760/cma.j.cn121381-202002014-00079
Zhang JM, Wang JF, Zhao XM.  Protection and management proposals on nuclear medicine diagnosis and treatment during the COVID-19 epidemic period[J]. Int J Radiat Med Nucl Med, 2020, 44(10): 622-626.   doi: 10.3760/cma.j.cn121381-202002014-00079
[5]

中华人民共和国国家卫生健康委员会办公厅. 新型冠状病毒实验室生物安全指南(第二版)[Z/OL]. 国卫办科教函[2020]70号. (2020-01-23)[2021-02-03]. http://www.nhc.gov.cn/xcs/zhengcwj/202001/0909555408d842a58828611dde2e6a26.shtml.

General Office of National Health Commission of the People's Republic of China. Laboratory biosafety guide of 2019 novel coronavirus (version 2)[Z/OL]. No. 70[2020] of the General Office of the National Health Commission. (2020-01-23)[2021-02-03]. http://www.nhc.gov.cn/xcs/zhengcwj/202001/0909555408d842a58828611dde2e6a26.shtml.
[6] 张小燕, 孙伟, 尚世强, 等.  2019冠状病毒病(COVID-19)疫情期生物样本保藏生物安全防护原则及建议[J]. 浙江大学学报(医学版), 2019, 49(2): 170-177.   doi: 10.3785/j.issn.1008-9292.2020.02.04
Zhang XY, Sun W, Shang SQ, et al.  Principles and suggestions on biosafety protection of biological specimen preservation during prevalence of COVID-19[J]. J Zhejiang Univ: Med Sci, 2019, 49(2): 170-177.   doi: 10.3785/j.issn.1008-9292.2020.02.04
[7]

Centers for Disease Control and Prevention. Healthcare Workers: Information on COVID-19[EB/OL]. (2020-02-05)[2021-02-03]. https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html.
[8] 张利君, 王文慧, 沙莉, 等.  新型冠状病毒肺炎病人血液标本采集和运送流程的制订及应用[J]. 护理研究, 2020, 34(6): 950-952.   doi: 10.12102/j.issn.1009-6493.2020.06.036
Zhang LJ, Wang WH, Sha L, et al.  Establishment and application of blood sample collection and delivery procedures for patients with corona virus disease 2019[J]. Chin Nurs Res, 2020, 34(6): 950-952.   doi: 10.12102/j.issn.1009-6493.2020.06.036